Form 4 filings across 1 company. Net figures count open-market buys and sales only. EDGAR profile ↗
Lifetime net: -$28.4M
Reported holding is the most recent post-transaction share count on a Table I row.
How quickly this filer reports. Section 16 allows two business days from the transaction.
All 7 filings we hold were filed within the two-business-day deadline.
Counted in business days from the transaction date, or the deemed execution date where the filing reports one, excluding weekends and federal holidays. How this is measured · All late filings
The 21 most recent Form 4 transactions.
| Feb 24 | VRTX | Vertex Pharmaceuticals… | FTAX◷ | 1,518 | $485.11 | $736.4K | -2.6% | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | MEXER◷◆ | 25,026 | — | — | — | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | MEXER◷◆ | 23,479 | — | — | — | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 4,237 | $471.43 | $2M | -6.7% | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 11,712 | $470.54 | $5.5M | -15.6% | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 7,241 | $469.61 | $3.4M | -8.8% | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 19,662 | $468.57 | $9.2M | -19.3% | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 10,263 | $467.75 | $4.8M | -9.2% | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 1,848 | $465.80 | $860.8K | -1.6% | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 2,730 | $465.05 | $1.3M | -2.3% | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | SSELL◷ | 920 | $463.91 | $426.8K | -0.8% | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | MEXER◷ | 25,026 | $187.53 | $4.7M | +27.1% | Open the original filing on SEC.gov |
| Feb 19 | VRTX | Vertex Pharmaceuticals… | MEXER◷ | 23,479 | $155.57 | $3.7M | +34.0% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | FTAX | 2,140 | $483.75 | $1M | -3.0% | Open the original filing on SEC.gov |
| Feb 17 | VRTX | Vertex Pharmaceuticals… | AGRANT | 5,789 | — | — | +8.8% | Open the original filing on SEC.gov |
| Feb 13 | VRTX | Vertex Pharmaceuticals… | FTAX | 3,548 | $487.76 | $1.7M | -5.1% | Open the original filing on SEC.gov |
| Feb 10 | VRTX | Vertex Pharmaceuticals… | FTAX | 2,057 | $468.41 | $963.5K | -2.9% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 3,883 | — | — | +5.8% | Open the original filing on SEC.gov |
| Jan 22 | VRTX | Vertex Pharmaceuticals… | AGRANT | 7,866 | — | — | +13.3% | Open the original filing on SEC.gov |